Skip to main content

The Wistar Institute

|

Congratulations to Dr. Qing Chen on receiving the 2019 Legacy of Hope Merit Award! 

Qing Chen, M.D., Ph.D., received the 2019 Legacy of Hope Merit Award in support of her research on how cancer spreads from a primary tumor, such as breast cancer, to the brain. Read more in the foundation’s blog featuring Chen and her research work.
|

Setting the Stage for Success: The Busy Life of a Graduate Student at Wistar

Gretchen Alicea is a graduate student at The Wistar Institute and is enrolled in the Ph.D. Program in Cancer Biology overseen jointly by Wistar and University of the Sciences (USciences). She has a lot on her plate: She is conducting exciting rese…
|

Major Grant Awarded to Wistar Supports Development of a Novel Therapeutic Approach for Antibiotic-resistant Bacteria

PHILADELPHIA — (September 12, 2019) — The Wistar Institute has received a grant of approximately $4.6 million from the National Institutes of Health in support of innovative research to tackle antibiotic resistance. Antimicrobial resistance (AMR) …
|

Role of Cancer Protein ARID1A at the Intersection of Genome Stability and Tumor Suppression

PHILADELPHIA — (Sept. 6, 2019) — The ARID1A tumor suppressor protein is required to maintain telomere cohesion and correct chromosome segregation after DNA replication. This finding, reported by Wistar researchers in Nature Communications, indicat…
|

The Wistar Institute and IMV Announce Research Collaboration to Develop New Targeted Immunotherapy Against the Common BRAF Cancer Mutation

PHILADELPHIA – (SEPT. 4, 2019) – The Wistar Institute, an international leader in biomedical research in cancer, immunology, infectious diseases, and vaccine creation, and IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage immuno-oncology company,…
|

Wistar Science is Launchpad for Creating First MERS Vaccine that Has Completed Phase 1 Human Trial

Using enhanced DNA vaccine technology, Wistar scientists can speed the development of vaccines for emerging diseases creating impactful countermeasures against outbreaks. Wistar’s Drs. Kar Muthumani, David Weiner and collaborators unlocked the R&a…
|

Beyond Vaccines: Looking to Cures for Infectious Diseases

New infectious diseases are on the rise: In 2015 and 2016, there was an upswing in Zika outbreaks in the U.S., and the virus still impacts many parts of the world. The Ebola epidemic in the Democratic Republic of Congo (DRC) is the second largest …
|

Repeated Semen Exposure Promotes Host Resistance to Infection in Preclinical Model of HIV

PHILADELPHIA — (Aug. 21, 2019) — Contrary to the long-held view that semen can only act as a way to transmit HIV-1 from men to women, scientists at The Wistar Institute and the University of Puerto Rico found that frequent and sustained semen expo…
|

Why Don’t We Respect Bacteria? First Symposium on Bacterial Resistance at Wistar

There is an antibiotic crunch happening globally and to address this stalemate, Wistar hosted its first gathering of top scientists working to combat antibiotic resistance.  The recent U.K. Review on Antimicrobial Resistance&nb…
|

Dr. Kazuko Nishikura: the RNA Explorer

Nishikura has been a pillar of Wistar science for the past 37 years with a career overlapping with the rise and expansion of the RNA biology field, which explores the alternative functions of RNA in the cell, besides carrying the genetic informati…